Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: Diagnostic experience 2001/2002 of a single research laboratory
Studt JD, Kremer Hovinga JA, Alberio L et al. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory. Swiss Med Wkly 2003; 133: 325-32.
New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: Case report and review
Häberle J, Kehrel B, Ritter J et al. New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review. Eur J Pediatr 1999; 158: 883-7.
Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma
Kentouche K, Budde U, Furlan M et al. Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma. Acta Paediatr 2002; 91: 1056-9.
Upshaw-Schulman syndrome revisited: A concept of congenital thrombotic thrombocypenic purpura
Kinoshita S, Yoshioka A, Park YD et al. Upshaw-Schulman syndrome revisited: A concept of congenital thrombotic thrombocypenic purpura. Int J Hematol 2001; 74: 101-8.
Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
Tsai HM, Lian ECH. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
Furlan M, Robles R, Galbusera M et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
Succesful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8Y
Lester WA, Williams MD, Allford SL et al. Succesful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8Y. Br J Haematol 2002; 119: 176-9.
Von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura
Allford SL, Harrison P, Lawrie AS et al. Von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura. Br J Haematol 2000; 111: 1215-22.